scholarly article | Q13442814 |
P2093 | author name string | F Haller | |
B Gunawan | |||
D Raddatz | |||
P Middel | |||
H-J Radzun | |||
P2860 | cites work | Naive T Cell Recruitment to Nonlymphoid Tissues: A Role for Endothelium-Expressed CC Chemokine Ligand 21 in Autoimmune Disease and Lymphoid Neogenesis | Q28198814 |
Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases | Q28209468 | ||
Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium | Q28216812 | ||
Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin | Q28217049 | ||
Expression of the T-cell chemoattractant chemokine lymphotactin in Crohn's disease | Q28363385 | ||
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs | Q28594485 | ||
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo | Q30080006 | ||
Lymphoid organ development and cell migration | Q31156611 | ||
The reduced expression of 6Ckine in the plt mouse results from the deletion of one of two 6Ckine genes | Q33877237 | ||
Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression | Q34118755 | ||
Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs | Q34756572 | ||
Dendritic cells, chemokine receptors and autoimmune inflammatory diseases | Q34842438 | ||
Innate immunity in the pathogenesis and therapy of IBD | Q35108558 | ||
Intestinal flora and mucosal immune responses | Q35130634 | ||
The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria | Q35217282 | ||
Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease | Q35366019 | ||
Chemokine regulation of naïve T cell traffic in health and disease | Q35682765 | ||
Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis | Q35747868 | ||
Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse | Q35822641 | ||
Targeting enteric bacteria in treatment of inflammatory bowel diseases: why, how, and when | Q36036286 | ||
Update in inflammatory bowel disease pathogenesis | Q36036554 | ||
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells | Q36369028 | ||
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues | Q36991047 | ||
T cells and cytokines in Crohn's disease | Q41716646 | ||
Phenotypic characterization of five dendritic cell subsets in human tonsils | Q42048373 | ||
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization | Q42064511 | ||
Mobilizing dendritic cells for tolerance, priming, and chronic inflammation | Q42576422 | ||
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
HOPE fixation: a novel fixing method and paraffin-embedding technique for human soft tissues. | Q43857467 | ||
The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. | Q43910951 | ||
Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. | Q46655434 | ||
Increased expression of CCL20 in human inflammatory bowel disease | Q48008663 | ||
Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation. | Q48390605 | ||
Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. | Q52051526 | ||
Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis | Q73100417 | ||
[Immunopathogenesis of inflammatory bowel diseases] | Q73419853 | ||
Migration and maturation of human colonic dendritic cells | Q73720830 | ||
Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease | Q73768616 | ||
Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis | Q74269386 | ||
Identification of lymphatic vessels in malignant, adenomatous and normal colonic mucosa using the novel immunostain D2-40 | Q79343157 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Crohn's disease | Q1472 |
dendritic cell | Q506253 | ||
P304 | page(s) | 220-227 | |
P577 | publication date | 2005-08-23 | |
P1433 | published in | Gut | Q5621669 |
P1476 | title | Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism | |
P478 | volume | 55 |
Q63727323 | 25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn’s disease |
Q42094524 | A mechanistic role for leptin in human dendritic cell migration: differences between ileum and colon in health and Crohn's disease. |
Q53497403 | A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis. |
Q33962421 | Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis. |
Q33325670 | Activation of tonsil dendritic cells with immuno-adjuvants |
Q37591672 | Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation |
Q41990281 | Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells |
Q36931389 | Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis |
Q39938297 | Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. |
Q37545473 | Bifidobacterium bifidum PRL2010 modulates the host innate immune response |
Q34609469 | CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions |
Q36095617 | CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. |
Q28583123 | CCR6 regulation of the actin cytoskeleton orchestrates human beta defensin-2- and CCL20-mediated restitution of colonic epithelial cells |
Q37073770 | CD83+CCR7- dendritic cells accumulate in the subepithelial dome and internalize translocated Escherichia coli HB101 in the Peyer's patches of ileal Crohn's disease. |
Q34749054 | Canine gut dendritic cells in the steady state and in inflammatory bowel disease |
Q36502254 | Characteristic expression and significance of CCL19 in different tissue types in chronic rhinosinusitis. |
Q34674064 | Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma |
Q36422559 | Characterization of plasmacytoid dendritic cells in bone marrow of pig-tailed macaques |
Q52347151 | Chemokine and chemotactic signals in dendritic cell migration. |
Q35627709 | Chemokine receptor CCR7 regulates the intestinal TH1/TH17/Treg balance during Crohn's-like murine ileitis |
Q33726199 | Chemokine-mediated distribution of dendritic cell subsets in renal cell carcinoma |
Q33964919 | Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease |
Q27687402 | Chemokines and chemokine receptors: update on utility and challenges for the clinician |
Q44782672 | Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation |
Q38911315 | Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection |
Q41817919 | Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease |
Q34999740 | Dendritic cell populations in patients with self-reported food hypersensitivity |
Q60050768 | Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel disease |
Q80199820 | Dendritic cells and toll-like receptors 2 and 4 in the ileum of Crohn's disease patients |
Q31126452 | Dendritic cells from Crohn's disease patients show aberrant STAT1 and STAT3 signaling |
Q37591719 | Dendritic cells in intestinal homeostasis and disease. |
Q96640775 | Difference in Presence and Number of CD83+ Dendritic Cells in Patients with Ulcerative Colitis and Crohn's Disease |
Q33633866 | Differential between protein and mRNA expression of CCR7 and SSTR5 receptors in Crohn's disease patients. |
Q41492918 | Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology |
Q36113094 | Enhanced expression of CCL20 in human Helicobacter pylori-associated gastritis |
Q43575647 | Enhanced levels of CCL19 in patients with advanced acquired immune deficiency syndrome (AIDS). |
Q90643852 | Identification of potential biomarkers and pathways in ulcerative colitis with combined public mRNA and miRNA expression microarray data analysis |
Q35857951 | Immunopathogenesis of IBD: current state of the art. |
Q45837304 | Impact of CCR7 on the gastrointestinal field effect |
Q90468717 | Inhibition of CD83 Alleviates Systemic Inflammation in Herpes Simplex Virus Type 1-Induced Behçet's Disease Model Mouse |
Q34568588 | Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. |
Q60046084 | Intestinal Dendritic Cells in Health and Gut Inflammation |
Q38182101 | Intestinal dendritic cell and macrophage subsets: Tipping the balance to Crohn's disease? |
Q37281018 | Intestinal dendritic cells and epithelial barrier dysfunction in Crohn's disease |
Q37754580 | Lymphangiogenesis, myeloid cells and inflammation |
Q38739268 | Lymphangiogenesis: fuel, smoke, or extinguisher of inflammation's fire? |
Q35691047 | Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. |
Q37786225 | Mucosal dendritic cell diversity in the gastrointestinal tract |
Q63727319 | Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn’s disease patients |
Q26864144 | Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology |
Q64094862 | Rapid Downregulation of DAB2 by Toll-Like Receptor Activation Contributes to a Pro-Inflammatory Switch in Activated Dendritic Cells |
Q53500011 | Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis. |
Q41899805 | SAMP1/YitFc mice develop ileitis via loss of CCL21 and defects in dendritic cell migration |
Q43696077 | Sequence variation in promoter regions of genes for CC chemokine ligands (CCL)19 and 21 in Czech patients with myocardial infarction |
Q43639621 | Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells |
Q33686549 | Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques |
Q35197000 | Targeted intestinal epithelial deletion of the chemokine receptor CXCR4 reveals important roles for extracellular-regulated kinase-1/2 in restitution |
Q53214538 | [History and perspectives of the monocyte-macrophage system]. |
Search more.